TWO SIGMA SECURITIES, LLC - PHIO PHARMACEUTICALS CORP ownership

PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 19 filers reported holding PHIO PHARMACEUTICALS CORP in Q4 2021. The put-call ratio across all filers is 3.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA SECURITIES, LLC ownership history of PHIO PHARMACEUTICALS CORP
ValueSharesWeighting
Q4 2022$7,331
-43.6%
19,707
-11.7%
0.00%
Q3 2022$13,000
+85.7%
22,316
+116.5%
0.00%
Q2 2022$7,000
-66.7%
10,307
-55.5%
0.00%
-100.0%
Q1 2022$21,000
+10.5%
23,175
+23.0%
0.00%0.0%
Q4 2021$19,000
-51.3%
18,842
+10.2%
0.00%0.0%
Q2 2021$39,00017,0990.00%
Other shareholders
PHIO PHARMACEUTICALS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
CVI Holdings, LLC 360,094$637,0002.24%
SABBY MANAGEMENT, LLC 255,194$452,0000.19%
EDMOND DE ROTHSCHILD HOLDING S.A. 12,500$22,0000.00%
UBS Group AG 563$1,0000.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
WELLS FARGO & COMPANY/MN 18$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HSBC HOLDINGS PLC 12,375$22,0000.00%
MORGAN STANLEY 86$00.00%
BlackRock Inc. 19$00.00%
View complete list of PHIO PHARMACEUTICALS CORP shareholders